EverCell Bio Highlighted in Life Sciences Review for Advancing hiPSC Technology
EverCell Bio was recently featured in Life Sciences Review for its work helping researchers apply human induced pluripotent stem cell (hiPSC) technology to disease modeling and therapeutic development. Recognized as one of the top stem cell service providers in 2025, EverCell Bio’s approach centers on a customizable and full-service platform that adapts to each client’s research needs while maintaining scientific rigor. The company’s processes include structured onboarding, tailored communication schedules, and workflows designed to integrate with client preferences and protocols.
The article highlights EverCell Bio’s expertise in cell reprogramming, gene editing, and differentiation, enabling academic and industry researchers to generate high-quality human cell models from patient-derived samples. By combining deep stem cell expertise with a flexible service platform, EverCell Bio helps research teams overcome technical challenges and accelerate discovery.
From producing specialized cells such as neurons and cardiomyocytes to supporting complex translational research programs, EverCell Bio provides the tools and scientific guidance needed to turn advanced stem cell technologies into practical research solutions.
Read the full article to learn more about EverCell Bio’s approach to hiPSC technology.
